Emmanouela Repapi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Emmanouela Repapi has a total of 408 co-authors. Here are the top co-authors by number of shared publications:
Stephen Taylor
Medical Research Council Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, Oxfordshire, OX3 9DS
9 shared publications- Paresh Vyas
MRC Weatherall Institute of Molecular Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
7 shared publications - Jim Raymond Hughes
MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
5 shared publications - Stephen Taylor
MRC WIMM Centre for Computational Biology, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
5 shared publications - Adam J. Mead
Medical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine and National Institute of Health Research, Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
4 shared publications David Sims
Medical Research Council Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, Oxfordshire, OX3 9DS
4 shared publications
Latest Publications
- Open Access
- 2 May 2023
- Published by F1000 Research Ltd in F1000Research
- Vol. 11, 560
Integration of single-cell RNA-Seq and CyTOF data characterises heterogeneity of rare cell subpopulations
Background: The simultaneous measurement of cellular proteins and transcriptomes of single cell data has become an exciting new possibility with the advent of highly multiplexed multi-omics methodologies. However, mass cytometry (CyTOF) is a well-established, affordable technique for the analysis of proteomic data, which is well suited for the discovery and characterisation of very rare subpopulations of cells with a wealth of publicly available datasets. Methods: We present and evaluate the multimodal integration of single cell RNA-Seq and CyTOF datasets coming from both matched and unmatched samples, using two publicly available datasets. Results: We demonstrate that the integration of well annotated CyTOF data with single cell RNA sequencing can aid in the identification and annotation of cell populations with high accuracy. Furthermore, we show that the integration can provide imputed measurements of protein markers which are comparable to the current gold standard of antibody derived tags (ADT) from CITE-Seq for both matched and unmatched datasets. Using this methodology, we identify and transcriptionally characterise a rare subpopulation of CD11c positive B cells in high resolution using publicly available data and we unravel its heterogeneity in a single cell setting without the need to sort the cells in advance, in a manner which had not been previously possible. Conclusions: This approach provides the framework for using available proteomic and transcriptomic datasets in a unified and unbiased fashion to assist ongoing and future studies of cellular characterisation and biomarker identification.
- 2 May 2023
- Published by F1000 Research Ltd in F1000Research
- Vol. 11, 560
Open AccessIntegration of single-cell RNA-Seq and CyTOF data characterises heterogeneity of rare cell subpopulations
Background: The simultaneous measurement of cellular proteins and transcriptomes of single cell data has become an exciting new possibility with the advent of highly multiplexed multi-omics methodologies. However, mass cytometry (CyTOF) is a well-established, affordable technique for the analysis of proteomic data, which is well suited for the discovery and characterisation of very rare subpopulations of cells with a wealth of publicly available datasets. Methods: We present and evaluate the multimodal integration of single cell RNA-Seq and CyTOF datasets coming from both matched and unmatched samples, using two publicly available datasets. Results: We demonstrate that the integration of well annotated CyTOF data with single cell RNA sequencing can aid in the identification and annotation of cell populations with high accuracy. Furthermore, we show that the integration can provide imputed measurements of protein markers which are comparable to the current gold standard of antibody derived tags (ADT) from CITE-Seq for both matched and unmatched datasets. Using this methodology, we identify and transcriptionally characterise a rare subpopulation of CD11c positive B cells in high resolution using publicly available data and we unravel its heterogeneity in a single cell setting without the need to sort the cells in advance, in a manner which had not been previously possible. Conclusions: This approach provides the framework for using available proteomic and transcriptomic datasets in a unified and unbiased fashion to assist ongoing and future studies of cellular characterisation and biomarker identification.
- Open Access
- 4 November 2022
- Published by F1000 Research Ltd in F1000Research
- Vol. 11, 560
Integration of single-cell RNA-Seq and CyTOF data characterises heterogeneity of rare cell subpopulations
Background: The simultaneous measurement of cellular proteins and transcriptomes of single cell data has become an exciting new possibility with the advent of highly multiplexed multi-omics methodologies. However, mass cytometry (CyTOF) is a well-established, affordable technique for the analysis of proteomic data, which is well suited for the discovery and characterisation of very rare subpopulations of cells with a wealth of publicly available datasets. Methods: We present and evaluate the multimodal integration of single cell RNA-Seq and CyTOF datasets coming from both matched and unmatched samples, using two publicly available datasets. Results: We demonstrate that the integration of well annotated CyTOF data with single cell RNA sequencing can aid in the identification and annotation of cell populations with high accuracy. Furthermore, we show that the integration can provide imputed measurements of protein markers which are comparable to the current gold standard of antibody derived tags (ADT) from CITE-Seq for both matched and unmatched datasets. Using this methodology, we identify and transcriptionally characterise a rare subpopulation of CD11c positive B cells in high resolution using publicly available data and we unravel its heterogeneity in a single cell setting without the need to sort the cells in advance, in a manner which had not been previously possible. Conclusions: This approach provides the framework for using available proteomic and transcriptomic datasets in a unified and unbiased fashion to assist ongoing and future studies of cellular characterisation and biomarker identification.
- 4 November 2022
- Published by F1000 Research Ltd in F1000Research
- Vol. 11, 560
Open AccessIntegration of single-cell RNA-Seq and CyTOF data characterises heterogeneity of rare cell subpopulations
Background: The simultaneous measurement of cellular proteins and transcriptomes of single cell data has become an exciting new possibility with the advent of highly multiplexed multi-omics methodologies. However, mass cytometry (CyTOF) is a well-established, affordable technique for the analysis of proteomic data, which is well suited for the discovery and characterisation of very rare subpopulations of cells with a wealth of publicly available datasets. Methods: We present and evaluate the multimodal integration of single cell RNA-Seq and CyTOF datasets coming from both matched and unmatched samples, using two publicly available datasets. Results: We demonstrate that the integration of well annotated CyTOF data with single cell RNA sequencing can aid in the identification and annotation of cell populations with high accuracy. Furthermore, we show that the integration can provide imputed measurements of protein markers which are comparable to the current gold standard of antibody derived tags (ADT) from CITE-Seq for both matched and unmatched datasets. Using this methodology, we identify and transcriptionally characterise a rare subpopulation of CD11c positive B cells in high resolution using publicly available data and we unravel its heterogeneity in a single cell setting without the need to sort the cells in advance, in a manner which had not been previously possible. Conclusions: This approach provides the framework for using available proteomic and transcriptomic datasets in a unified and unbiased fashion to assist ongoing and future studies of cellular characterisation and biomarker identification.
- Open Access
- 17 June 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-16
The chromatin remodeller ATRX facilitates diverse nuclear processes, in a stochastic manner, in both heterochromatin and euchromatin
The chromatin remodeller ATRX interacts with the histone chaperone DAXX to deposit the histone variant H3.3 at sites of nucleosome turnover. ATRX is known to bind repetitive, heterochromatic regions of the genome including telomeres, ribosomal DNA and pericentric repeats, many of which are putative G-quadruplex forming sequences (PQS). At these sites ATRX plays an ancillary role in a wide range of nuclear processes facilitating replication, chromatin modification and transcription. Here, using an improved protocol for chromatin immunoprecipitation, we show that ATRX also binds active regulatory elements in euchromatin. Mutations in ATRX lead to perturbation of gene expression associated with a reduction in chromatin accessibility, histone modification, transcription factor binding and deposition of H3.3 at the sequences to which it normally binds. In erythroid cells where downregulation of α-globin expression is a hallmark of ATR-X syndrome, perturbation of chromatin accessibility and gene expression occurs in only a subset of cells. The stochastic nature of this process suggests that ATRX acts as a general facilitator of cell specific transcriptional and epigenetic programmes, both in heterochromatin and euchromatin.
- 17 June 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-16
Open AccessThe chromatin remodeller ATRX facilitates diverse nuclear processes, in a stochastic manner, in both heterochromatin and euchromatin
The chromatin remodeller ATRX interacts with the histone chaperone DAXX to deposit the histone variant H3.3 at sites of nucleosome turnover. ATRX is known to bind repetitive, heterochromatic regions of the genome including telomeres, ribosomal DNA and pericentric repeats, many of which are putative G-quadruplex forming sequences (PQS). At these sites ATRX plays an ancillary role in a wide range of nuclear processes facilitating replication, chromatin modification and transcription. Here, using an improved protocol for chromatin immunoprecipitation, we show that ATRX also binds active regulatory elements in euchromatin. Mutations in ATRX lead to perturbation of gene expression associated with a reduction in chromatin accessibility, histone modification, transcription factor binding and deposition of H3.3 at the sequences to which it normally binds. In erythroid cells where downregulation of α-globin expression is a hallmark of ATR-X syndrome, perturbation of chromatin accessibility and gene expression occurs in only a subset of cells. The stochastic nature of this process suggests that ATRX acts as a general facilitator of cell specific transcriptional and epigenetic programmes, both in heterochromatin and euchromatin.
- Open Access
- 23 May 2022
- Published by F1000 Research Ltd in F1000Research
- Vol. 11, 560
Integration of single-cell RNA-Seq and CyTOF data characterises heterogeneity of rare cell subpopulations
Background: The simultaneous measurement of cellular proteins and transcriptomes of single cell data has become an exciting new possibility with the advent of highly multiplexed multi-omics methodologies. However, mass cytometry (CyTOF) is a well-established, affordable technique for the analysis of proteomic data, which is well suited for the discovery and characterisation of very rare subpopulations of cells with a wealth of publicly available datasets. Methods: We present and evaluate the multimodal integration of single cell RNA-Seq and CyTOF datasets coming from both matched and unmatched samples, using two publicly available datasets. Results: We demonstrate that the integration of well annotated CyTOF data with single cell RNA sequencing can aid in the identification and annotation of cell populations with high accuracy. Furthermore, we show that the integration can provide imputed measurements of protein markers which are comparable to the current gold standard of antibody derived tags (ADT) from CITE-Seq for both matched and unmatched datasets. Using this methodology, we identify and transcriptionally characterise a rare subpopulation of CD11c positive B cells in high resolution using publicly available data and we unravel its heterogeneity in a single cell setting without the need to sort the cells in advance, in a manner which had not been previously possible. Conclusions: This approach provides the framework for using available proteomic and transcriptomic datasets in a unified and unbiased fashion to assist ongoing and future studies of cellular characterisation and biomarker identification.
- 23 May 2022
- Published by F1000 Research Ltd in F1000Research
- Vol. 11, 560
Open AccessIntegration of single-cell RNA-Seq and CyTOF data characterises heterogeneity of rare cell subpopulations
Background: The simultaneous measurement of cellular proteins and transcriptomes of single cell data has become an exciting new possibility with the advent of highly multiplexed multi-omics methodologies. However, mass cytometry (CyTOF) is a well-established, affordable technique for the analysis of proteomic data, which is well suited for the discovery and characterisation of very rare subpopulations of cells with a wealth of publicly available datasets. Methods: We present and evaluate the multimodal integration of single cell RNA-Seq and CyTOF datasets coming from both matched and unmatched samples, using two publicly available datasets. Results: We demonstrate that the integration of well annotated CyTOF data with single cell RNA sequencing can aid in the identification and annotation of cell populations with high accuracy. Furthermore, we show that the integration can provide imputed measurements of protein markers which are comparable to the current gold standard of antibody derived tags (ADT) from CITE-Seq for both matched and unmatched datasets. Using this methodology, we identify and transcriptionally characterise a rare subpopulation of CD11c positive B cells in high resolution using publicly available data and we unravel its heterogeneity in a single cell setting without the need to sort the cells in advance, in a manner which had not been previously possible. Conclusions: This approach provides the framework for using available proteomic and transcriptomic datasets in a unified and unbiased fashion to assist ongoing and future studies of cellular characterisation and biomarker identification.
- 21 May 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 6 (59)
IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent
Cutaneous group 2 innate lymphoid cells (ILC2) are spatially and epigenetically poised to respond to barrier compromise and associated immunological threats. ILC2, lacking rearranged antigen-specific receptors, are primarily activated by damage-associated cytokines and respond with type 2 cytokine production. To investigate ILC2 potential for direct sensing of skin pathogens and allergens, we performed RNA sequencing of ILC2 derived from in vivo challenged human skin or blood. We detected expression of NOD2 and TLR2 by skin and blood ILC2. Stimulation of ILC2 with TLR2 agonist alone not only induced interleukin-5 (IL-5) and IL-13 expression but also elicited IL-6 expression in combination with Staphylococcus aureus muramyl dipeptide (MDP). Heat-killed skin-resident bacteria provoked an IL-6 profile in ILC2 in vitro that was notably impaired in ILC2 derived from patients with nucleotide-binding oligomerization domain-containing protein 2 (NOD2) mutations. In addition, we show that NOD2 signaling can stimulate autophagy in ILC2, which was also impaired in patients with NOD2 mutations. Here, we have identified a role for ILC2 NOD2 signaling in the differential regulation of ILC2-derived IL-6 and have reported a previously unrecognized pathway of direct ILC2 bacterial sensing.
- 21 May 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 6 (59)
IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent
Cutaneous group 2 innate lymphoid cells (ILC2) are spatially and epigenetically poised to respond to barrier compromise and associated immunological threats. ILC2, lacking rearranged antigen-specific receptors, are primarily activated by damage-associated cytokines and respond with type 2 cytokine production. To investigate ILC2 potential for direct sensing of skin pathogens and allergens, we performed RNA sequencing of ILC2 derived from in vivo challenged human skin or blood. We detected expression of NOD2 and TLR2 by skin and blood ILC2. Stimulation of ILC2 with TLR2 agonist alone not only induced interleukin-5 (IL-5) and IL-13 expression but also elicited IL-6 expression in combination with Staphylococcus aureus muramyl dipeptide (MDP). Heat-killed skin-resident bacteria provoked an IL-6 profile in ILC2 in vitro that was notably impaired in ILC2 derived from patients with nucleotide-binding oligomerization domain-containing protein 2 (NOD2) mutations. In addition, we show that NOD2 signaling can stimulate autophagy in ILC2, which was also impaired in patients with NOD2 mutations. Here, we have identified a role for ILC2 NOD2 signaling in the differential regulation of ILC2-derived IL-6 and have reported a previously unrecognized pathway of direct ILC2 bacterial sensing.
- Open Access
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Summary: Treatment of severe COVID-19 is currently limited by clinical heterogeneity and incomplete understanding of potentially druggable immune mediators of disease. To advance this, we present a comprehensive multi-omic blood atlas in patients with varying COVID-19 severity and compare with influenza, sepsis and healthy volunteers. We identify immune signatures and correlates of host response. Hallmarks of disease severity revealed cells, their inflammatory mediators and networks as potential therapeutic targets, including progenitor cells and specific myeloid and lymphocyte subsets, features of the immune repertoire, acute phase response, metabolism and coagulation. Persisting immune activation involving AP-1/p38MAPK was a specific feature of COVID-19. The plasma proteome enabled sub-phenotyping into patient clusters, predictive of severity and outcome. Tensor and matrix decomposition of the overall dataset revealed feature groupings linked with disease severity and specificity. Our systems-based integrative approach and blood atlas will inform future drug development, clinical trial design and personalised medicine approaches for COVID-19.
Open AccessA blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Summary: Treatment of severe COVID-19 is currently limited by clinical heterogeneity and incomplete understanding of potentially druggable immune mediators of disease. To advance this, we present a comprehensive multi-omic blood atlas in patients with varying COVID-19 severity and compare with influenza, sepsis and healthy volunteers. We identify immune signatures and correlates of host response. Hallmarks of disease severity revealed cells, their inflammatory mediators and networks as potential therapeutic targets, including progenitor cells and specific myeloid and lymphocyte subsets, features of the immune repertoire, acute phase response, metabolism and coagulation. Persisting immune activation involving AP-1/p38MAPK was a specific feature of COVID-19. The plasma proteome enabled sub-phenotyping into patient clusters, predictive of severity and outcome. Tensor and matrix decomposition of the overall dataset revealed feature groupings linked with disease severity and specificity. Our systems-based integrative approach and blood atlas will inform future drug development, clinical trial design and personalised medicine approaches for COVID-19.
- Open Access
- 11 January 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-15
BET inhibition disrupts transcription but retains enhancer-promoter contact
Enhancers are DNA sequences that enable complex temporal and tissue-specific regulation of genes in higher eukaryotes. Although it is not entirely clear how enhancer-promoter interactions can increase gene expression, this proximity has been observed in multiple systems at multiple loci and is thought to be essential for the maintenance of gene expression. Bromodomain and Extra-Terminal domain (BET) and Mediator proteins have been shown capable of forming phase condensates and are thought to be essential for super-enhancer function. Here, we show that targeting of cells with inhibitors of BET proteins or pharmacological degradation of BET protein Bromodomain-containing protein 4 (BRD4) has a strong impact on transcription but very little impact on enhancer-promoter interactions. Dissolving phase condensates reduces BRD4 and Mediator binding at enhancers and can also strongly affect gene transcription, without disrupting enhancer-promoter interactions. These results suggest that activation of transcription and maintenance of enhancer-promoter interactions are separable events. Our findings further indicate that enhancer-promoter interactions are not dependent on high levels of BRD4 and Mediator, and are likely maintained by a complex set of factors including additional activator complexes and, at some sites, CTCF and cohesin.
- 11 January 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-15
Open AccessBET inhibition disrupts transcription but retains enhancer-promoter contact
Enhancers are DNA sequences that enable complex temporal and tissue-specific regulation of genes in higher eukaryotes. Although it is not entirely clear how enhancer-promoter interactions can increase gene expression, this proximity has been observed in multiple systems at multiple loci and is thought to be essential for the maintenance of gene expression. Bromodomain and Extra-Terminal domain (BET) and Mediator proteins have been shown capable of forming phase condensates and are thought to be essential for super-enhancer function. Here, we show that targeting of cells with inhibitors of BET proteins or pharmacological degradation of BET protein Bromodomain-containing protein 4 (BRD4) has a strong impact on transcription but very little impact on enhancer-promoter interactions. Dissolving phase condensates reduces BRD4 and Mediator binding at enhancers and can also strongly affect gene transcription, without disrupting enhancer-promoter interactions. These results suggest that activation of transcription and maintenance of enhancer-promoter interactions are separable events. Our findings further indicate that enhancer-promoter interactions are not dependent on high levels of BRD4 and Mediator, and are likely maintained by a complex set of factors including additional activator complexes and, at some sites, CTCF and cohesin.
- 3 August 2020
- Published by Springer Nature in Nature Medicine
- Vol. 26 (9) , 1480-1490
Single-cell atlas of colonic CD8+ T cells in ulcerative colitis
Colonic antigen-experienced lymphocytes such as tissue-resident memory CD8+ T cells can respond rapidly to repeated antigen exposure. However, their cellular phenotypes and the mechanisms by which they drive immune regulation and inflammation remain unclear. Here we compiled an unbiased atlas of human colonic CD8+ T cells in health and ulcerative colitis (UC) using single-cell transcriptomics with T-cell receptor repertoire analysis and mass cytometry. We reveal extensive heterogeneity in CD8+ T-cell composition, including expanded effector and post-effector terminally differentiated CD8+ T cells. While UC-associated CD8+ effector T cells can trigger tissue destruction and produce tumor necrosis factor (TNF)-α, post-effector cells acquire innate signatures to adopt regulatory functions that may mitigate excessive inflammation. Thus, we identify colonic CD8+ T-cell phenotypes in health and UC, define their clonal relationships and characterize terminally differentiated dysfunctional UC CD8+ T cells expressing IL-26, which attenuate acute colitis in a humanized IL-26 transgenic mouse model.
- 3 August 2020
- Published by Springer Nature in Nature Medicine
- Vol. 26 (9) , 1480-1490
Single-cell atlas of colonic CD8+ T cells in ulcerative colitis
Colonic antigen-experienced lymphocytes such as tissue-resident memory CD8+ T cells can respond rapidly to repeated antigen exposure. However, their cellular phenotypes and the mechanisms by which they drive immune regulation and inflammation remain unclear. Here we compiled an unbiased atlas of human colonic CD8+ T cells in health and ulcerative colitis (UC) using single-cell transcriptomics with T-cell receptor repertoire analysis and mass cytometry. We reveal extensive heterogeneity in CD8+ T-cell composition, including expanded effector and post-effector terminally differentiated CD8+ T cells. While UC-associated CD8+ effector T cells can trigger tissue destruction and produce tumor necrosis factor (TNF)-α, post-effector cells acquire innate signatures to adopt regulatory functions that may mitigate excessive inflammation. Thus, we identify colonic CD8+ T-cell phenotypes in health and UC, define their clonal relationships and characterize terminally differentiated dysfunctional UC CD8+ T cells expressing IL-26, which attenuate acute colitis in a humanized IL-26 transgenic mouse model.
- Open Access
- 4 October 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-15
Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease
Multiple myeloma is an incurable, bone marrow-dwelling malignancy that disrupts bone homeostasis causing skeletal damage and pain. Mechanisms underlying myeloma-induced bone destruction are poorly understood and current therapies do not restore lost bone mass. Using transcriptomic profiling of isolated bone lining cell subtypes from a murine myeloma model, we find that bone morphogenetic protein (BMP) signalling is upregulated in stromal progenitor cells. BMP signalling has not previously been reported to be dysregulated in myeloma bone disease. Inhibition of BMP signalling in vivo using either a small molecule BMP receptor antagonist or a solubilized BMPR1a-FC receptor ligand trap prevents trabecular and cortical bone volume loss caused by myeloma, without increasing tumour burden. BMP inhibition directly reduces osteoclastogenesis, increases osteoblasts and bone formation, and suppresses bone marrow sclerostin levels. In summary we describe a novel role for the BMP pathway in myeloma-induced bone disease that can be therapeutically targeted.
- 4 October 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-15
Open AccessTranscriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease
Multiple myeloma is an incurable, bone marrow-dwelling malignancy that disrupts bone homeostasis causing skeletal damage and pain. Mechanisms underlying myeloma-induced bone destruction are poorly understood and current therapies do not restore lost bone mass. Using transcriptomic profiling of isolated bone lining cell subtypes from a murine myeloma model, we find that bone morphogenetic protein (BMP) signalling is upregulated in stromal progenitor cells. BMP signalling has not previously been reported to be dysregulated in myeloma bone disease. Inhibition of BMP signalling in vivo using either a small molecule BMP receptor antagonist or a solubilized BMPR1a-FC receptor ligand trap prevents trabecular and cortical bone volume loss caused by myeloma, without increasing tumour burden. BMP inhibition directly reduces osteoclastogenesis, increases osteoblasts and bone formation, and suppresses bone marrow sclerostin levels. In summary we describe a novel role for the BMP pathway in myeloma-induced bone disease that can be therapeutically targeted.
- Open Access
- 26 June 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-15
DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation
Enhancer elements are a key regulatory feature of many important genes. Several general features including the presence of specific histone modifications are used to demarcate potentially active enhancers. Here we reveal that putative enhancers marked with H3 lysine 79 (H3K79) di or trimethylation (me2/3) (which we name H3K79me2/3 enhancer elements or KEEs) can be found in multiple cell types. Mixed lineage leukemia gene (MLL) rearrangements (MLL-r) such as MLL-AF4 are a major cause of incurable acute lymphoblastic leukemias (ALL). Using the DOT1L inhibitor EPZ-5676 in MLL-AF4 leukemia cells, we show that H3K79me2/3 is required for maintaining chromatin accessibility, histone acetylation and transcription factor binding specifically at KEEs but not non-KEE enhancers. We go on to show that H3K79me2/3 is essential for maintaining enhancer-promoter interactions at a subset of KEEs. Together, these data implicate H3K79me2/3 as having a functional role at a subset of active enhancers in MLL-AF4 leukemia cells.
- 26 June 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-15
Open AccessDOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation
Enhancer elements are a key regulatory feature of many important genes. Several general features including the presence of specific histone modifications are used to demarcate potentially active enhancers. Here we reveal that putative enhancers marked with H3 lysine 79 (H3K79) di or trimethylation (me2/3) (which we name H3K79me2/3 enhancer elements or KEEs) can be found in multiple cell types. Mixed lineage leukemia gene (MLL) rearrangements (MLL-r) such as MLL-AF4 are a major cause of incurable acute lymphoblastic leukemias (ALL). Using the DOT1L inhibitor EPZ-5676 in MLL-AF4 leukemia cells, we show that H3K79me2/3 is required for maintaining chromatin accessibility, histone acetylation and transcription factor binding specifically at KEEs but not non-KEE enhancers. We go on to show that H3K79me2/3 is essential for maintaining enhancer-promoter interactions at a subset of KEEs. Together, these data implicate H3K79me2/3 as having a functional role at a subset of active enhancers in MLL-AF4 leukemia cells.